Skip to main content
Clinical Trials/ISRCTN53821378
ISRCTN53821378
Completed
Not Applicable

Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux

Schering Plough International (USA)0 sites117 target enrollmentAugust 11, 2003

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic hepatitis C
Sponsor
Schering Plough International (USA)
Enrollment
117
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2003
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Schering Plough International (USA)

Eligibility Criteria

Inclusion Criteria

  • Patients with chronic hepatitis C and elevated transaminases who did not respond to previous treatment with standard interferon monotherapy.

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials